Efficacy of probiotics in helicobacter pylori eradication therapy

Journal of Clinical Gastroenterology

Volumn 47, Issue 9, 2013, Pages 814-815

  Dai, Cong ^a   Zheng, Chang Qing ^a   Jiang, Min ^b  

^a First Affiliated Hospital   (China)

^b CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CLARITHROMYCIN; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PROBIOTIC AGENT;

ANTIBIOTIC THERAPY; BACTERIAL CLEARANCE; COLONY FORMING UNIT; CROHN DISEASE; DIET SUPPLEMENTATION; DRUG EFFICACY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; ILEUM; INCIDENCE; INTESTINE FLORA; IRRITABLE COLON; JEJUNUM; LETTER; NONHUMAN; PANETH CELL; PRIORITY JOURNAL; STOMACH ACID; TREATMENT DURATION; ULCERATIVE COLITIS;

BIFIDOBACTERIUM; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; LACTOBACILLUS; PROBIOTICS;

EID: 84884675975     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e318298a32c     Document Type: Letter

References (4)

1. Wang ZH, Gao QY, Fang JY. Metaanalysis of the efficacy and safety of Lactobacillus-containing and Bifidobacterium-containing probiotic compound preparation in Helicobacter pylori eradication therapy. J Clin Gastroenterol. 2013;47:25-32.
2. Spiller R. Review article: Probiotics and prebiotics in irritable bowel syndrome. Aliment Pharmacol Ther. 2008;28: 385-396.
3. Whelan K, Quigley EM. Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Curr Opin Gastroenterol. 2013;29:184-189.
4. Hosseini A, Nikfar S, Abdollahi M. Probiotics use to treat irritable bowel syndrome. Expert Opin Biol Ther. 2012; 12:1323-1334.